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The intestinal microbiota is important for induction of
inflammatory bowel disease (IBD). IBD is associated
with complex shifts in microbiota composition, but it
is unclear whether specific bacterial subsets induce
IBD and, if so, whether their proportions in the micro-
biota are altered during disease. Here, we fulfilled
Koch’s postulates in host-genotype-specific fashion
using a mouse model of IBD with human-relevant
disease-susceptibility mutations. From screening
experimentswe isolatedcommoncommensalBacter-
oides species, introduced them into antibiotic-pre-
treated mice, and quantitatively reisolated them in
culture. The bacteria colonized IBD-susceptible and
-nonsusceptible mice equivalently, but induced
disease exclusively in susceptible animals. Con-
versely, commensal Enterobacteriaceae were >100-
fold enriched during spontaneous disease, but an
Enterobacteriaceae isolate failed to induce disease
in antibiotic-pretreated mice despite robust coloniza-
tion.We thusdemonstrate that IBD-associatedmicro-
biota alterations do not necessarily reflect underlying
disease etiology. These findings establish important
experimental criteria and a conceptual framework for
understanding microbial contributions to IBD.
INTRODUCTION
Inflammatory bowel disease (IBD) arises from complex interac-
tions of genetic, environmental, and microbial factors (Xavier
and Podolsky, 2007). IBD is a spectrum of chronic, noncommu-
nicable diseases primarily defined by spontaneous intestinal
inflammation. The two major subtypes, ulcerative colitis and
Crohn’s disease, exhibit distinct and overlapping clinical and
pathologic features (Stenson et al., 2009). Recent progress in
IBD host genetics has provided a critical framework to evaluate
microbial contributions to pathogenesis (Cadwell et al., 2010).
One important challenge is to understand the role of commensal
bacteria in the context of specific host genotypes.
Host genetics influence IBD susceptibility (Xavier and Podol-
sky, 2007). Recent meta-analyses of genome-wide association390 Cell Host & Microbe 9, 390–403, May 19, 2011 ª2011 Elsevier Instudies identified approximately 100susceptibility loci associated
with ulcerative colitis, Crohn’s disease, or both IBD subtypes
(Franke et al., 2010; McGovern et al., 2010). A subset of these
susceptibility loci are associated with signaling pathways for
IL-10andTGF-b, two immunoregulatorycytokineswithprominent
roles in intestinal homeostasis (Li et al., 2006;Ouyanget al., 2011).
These susceptibility alleles are common gene variants that
modestly elevate disease risk. Importantly, rare recessive defi-
ciencies in the IL-10 receptor result in fulminant, rapid-onset IBD
enterocolitis within one year of age (Glocker et al., 2009).
The intestinal microbiota also plays an important role in IBD
pathogenesis (Xavier and Podolsky, 2007). The microbiota
includes a large and diverse community of commensal bacterial
species identified by culture and culture-independent methods
(Eckburg et al., 2005; Qin et al., 2010). Both clinical and labora-
tory data implicate the microbiota in IBD induction. Medically,
antibiotics provide some therapeutic benefits to IBD patients
(Ohkusa et al., 2010; Sartor, 2008). In Crohn’s disease patients,
surgical diversion of fecal flow produces remission in inflamed
bowel segments with disease recurrence upon flow restoration
(Janowitz et al., 1998). Experimental introduction of small bowel
effluent into the surgically excluded bowel segments also rein-
duced disease, but a sterile ultrafiltrate of bowel effluent did
not (Harper et al., 1985). In most spontaneous animal models
of IBD, disease can be blocked by antibiotics or rederivation
into a germ-free state. IBD-susceptible germ-free animals
develop disease when exposed to commensal microbes from
conventionally raised hosts (Sartor, 2008). Mass sequencing
studies of the intestinal microbiota have revealed complex
disease-associated shifts in microbiota composition, but
disease is thus far not consistently associated with presence
or absence of a specific microbe (Frank et al., 2007; Packey
and Sartor, 2009; Qin et al., 2010).
Two related, fundamental questions about the role of the mi-
crobiota in IBD remain unresolved: in genetically susceptible
hosts, do specific subsets of commensal bacteria induce IBD
(Strober, 2010; Takaishi et al., 2008) and, if so, can these subsets
be identified based on disease-associated alterations in levels of
colonization (Tannock, 2008)? Functional tests of the ability of
specific microbes to induce IBD have relied primarily on germ-
free IBD-susceptible animals. These studies demonstrate that
select commensal bacterial species can induce disease in
some models (Sartor, 2008). However, translating these findings
to conventionally raised animal models, which more closely
mimic IBD patients, is challenging. Development of experimentalc.
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Bacteroides Induce Disease in Mice with IBDapproaches using conventionally raised animals to functionally
assess the roles of specific commensal bacteria and test hypoth-
eses generated by culture-independent microbiota profiling is
a critical priority.
Here, we address these questions using non-germ-free
methods in an antibiotic-responsive mousemodel with IBD-rele-
vant deficiencies in IL-10 and TGF-b signaling. We fulfill host-
genotype-specific Koch’s postulates by isolating commensal
bacteria, introducing them into antibiotic-pretreated mice, as-
sessing disease development, and confirming host colonization
by quantitative reisolation of the experimentally introduced
bacteria. We identify distinct commensal bacterial subsets with
and without disease-inducing potential in susceptible hosts and
show that these subsets would not have been predicted based
on disease-associated alterations in microbiota composition.
RESULTS
Establishment of a Non-Germ-free System to Screen
for Disease-Inducing Microbes Using dnKO Mice
We evaluated the colitogenic potential of intestinal microbes in
the dnKO mouse model of IBD (Kang et al., 2008). These mice
contain a complete knockout of Il10r2 (Spencer et al., 1998)
and express a transgene-encoded dominant-negative Tgfbr2
restricted to T cells (Gorelik and Flavell, 2000). Both mutations
are closely linked to pathways implicated in human IBD: IL10
and IL10RB (Franke et al., 2010; Glocker et al., 2009; McGovern
et al., 2010) and SMAD3, a direct downstream target of TGFBR2
(Franke et al., 2010). We previously showed that dnKO mice
develop spontaneous, severe, and rapid intestinal inflammation
that is 100% penetrant (Kang et al., 2008). Cohoused Il10r2+/
littermate controls did not develop colitis, suggesting the micro-
bial triggers of disease in dnKOmice were innocuous in nonsus-
ceptible hosts (Figure 1A). Colitis in dnKO mice was highly
responsive to treatment with metronidazole and ciprofloxacin
(Figure 1A). We quantified colitis severity in several anatomically
defined regions of the colon using previously validatedmetrics of
gross and anatomic pathology (Kang et al., 2008). Intestinal
whole mounts were scored for gross pathology in a blinded
fashion (Figure S1). Histologic mucosal inflammation, which is
a sensitive indicator of colitis severity, was quantified by
measuring heights and widths of well-oriented colonic crypts
(Kang et al., 2008). By these criteria, antibiotic treatment
completely blocked dnKO colitis (Figures 1B–1G).
Since the combination of antibiotics we used does not sterilize
the gut (Heimesaat et al., 2006), we hypothesized that disease in
dnKO mice would depend on a subset of commensal bacteria
that are eliminated by antibiotic treatment. The intestinal micro-
biota is normally dominated by members of two bacterial phyla:
Firmicutes (Gram-positive) and Bacteroidetes (Gram-negative)
(Eckburg et al., 2005). To assess the effects of antibiotics on
the microbiota, we collected fecal samples from antibiotic-
treated and untreated mice and performed qPCR using 16S
rRNA gene primer sets specific for the Bacteroidetes families
Bacteroidaceae, Porphyromonadaceae, and Prevotellaceae
(BPP) and for the Firmicutes families Enterococcaceae, Lactoba-
cillaceae, and Lachnospiraceae-Ruminococcaceae (Nava et al.,
2011). Antibiotic-treated mice showed a decrease in BPP and
Lachnospiraceae-Ruminococcaceae,whereasEnterococcaceaeCelland Lactobacillaceae were increased (Figure S2). These data
supported the hypothesis that antibiotic treatment prevented
disease by selectively altering subsets of commensal bacteria
within the microbiota.
To test this hypothesis, we developed a non-germ-free screen
for colitogenic activity of commensal bacteria, taking advantage
of the dnKO model’s rapid disease onset and antibiotic respon-
siveness. We housed mice in a specific pathogen-free facility
using stringent precautions to prevent cage-to-cage contamina-
tion. We treated dnKO and control mice at weaning with antibi-
otics forR3 weeks. Two days after halting antibiotic treatment,
mice were orogastrically gavaged a single time with experi-
mental inocula or sterile PBS as a control (Figure 2A). We found
that antibiotic-pretreated dnKO mice gavaged with sterile PBS
remained disease free (Figures 2B–2H). To demonstrate that
we could induce disease in this system, we gavaged antibiotic-
pretreated dnKO mice with intestinal contents harvested from
untreated control animals from our colony. We used a standard-
ized frozen stock of intestinal contents to control for microbiota
variation between individual donors (Weinstein et al., 1974). Mice
gavaged with freshly thawed aliquots of intestinal contents
developed severe colitis by 3 weeks after inoculation (Figures
2B–2H). Gavage with freshly harvested intestinal contents or
cohousing with untreated mice produced similar outcomes
(data not shown). The predominant site of pathology was the
colon withminor more variable effects in the lung and liver similar
to the pathology that developed in postweaning, untreated,
dnKO mice (Gorelik and Flavell, 2000; Kang et al., 2008). We
therefore relied on colon-specific metrics of colitis to ensure
results were not confounded by extraintestinal processes. These
results demonstrated the feasibility of our methods of screening
for colitogenic bacteria.
Mixed Cultures of Intestinal Microbes Induce Disease
in Antibiotic-Pretreated Mice
Wenext askedwhether cultivable intestinal bacteria could induce
colitis in this system. Because of the rapid andwidespread colitis
in dnKO mice, we hypothesized that common, abundant
members of the intestinal microbiota would induce disease. As
an initial screen, we serially diluted stock intestinal contents
from untreated mice (see above) and cultured the dilutions in
parallel on nonselective and selective bacterial growth media
(Figure 3A). We harvested anaerobic mixed cultures from a dilu-
tion at which 1500 colonies grew, ensuring cultures contained
only relatively abundant (approximately R0.07% abundance)
intestinal bacterial cultivable on that media type (Table S1). For
colonization experiments, anaerobic cultures were mixed in
equal proportionwith a culture grown aerobically on nonselective
media and gavaged into antibiotic-pretreated dnKO mice. Mice
gavaged with these cultures developed severe colitis relative to
PBS-gavaged controls (Figures 3B–3E), demonstrating that
colitis-inducing bacteria could be grown in culture.
To refine potential pools of colitogenic microbes, we tested
cultures grown on more selective media types including LKV
agar (to select for Gram-negative obligate anaerobes) or CNA
agar (to inhibit Gram-negative bacilli and enrich for Gram-posi-
tive anaerobes) (Figure 3A). Gavage mixtures were prepared as
above. Pathology in mice receiving the CNA culture did not
significantly differ from PBS-gavaged controls (Figures 3B–3E).Host & Microbe 9, 390–403, May 19, 2011 ª2011 Elsevier Inc. 391
Figure 1. Antibiotic Treatment Quantitatively Prevents Colitis Development in dnKO Mice
(A) Representative images of H&E-stained rectal histology of 4-week-old untreated and antibiotic-treated Il10r2+/ and dnKOmice (distal 0.5 cm of colon). Abx =
antibiotics (metronidazole + ciprofloxacin in drinking water). Scale bar = 100 mm.
(B and C) Cecum and transverse colon gross pathology scores of untreated and antibiotic-treated Il10r2+/ and dnKO mice as described in (A). Intestinal whole
mounts were scored according to a validated system: ranging from 0 (no pathology) to 3 (severe pathology) (see Figure S1 for details). Individual (squares) and
median (bars) pathology scores are displayed. Kruskal-Wallis test: H3 = 13.75, p = 0.0033 (B); H3 = 13.75, p = 0.0033 (C).
(D–G) Transverse colon and rectum crypt heights and crypt widths of mice, as described in (B) and (C), displayed asmean ± SEM, one-way ANOVAwith post hoc
Tukey’s test: F3,11 = 40.87, p < 0.0001 (D); F3,11 = 10.71, p = 0.0014 (E); F3,11 = 33.25, p < 0.0001 (F); F3,11 = 9.501, p = 0.0022 (G). All statistically significant pairwise
comparisons are displayed: **p < 0.01, ***p < 0.005. See also Figure S1.
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Bacteroides Induce Disease in Mice with IBDTo evaluate why the CNA culture did not induce disease, we iso-
lated bacteria from the feces of antibiotic-treated (noncolitic)
dnKO mice using nonselective ANB agar, extracted genomic
DNA, and obtained partial 16S rRNA gene sequences. Sequence
analysis showed the isolates belonged to a variety of families
within the phylum Firmicutes, including Enterococcaceae, Lac-
tobacillaceae, Bacillaceae, and Lachnospiraceae (Table S2). All
of the isolates grew on CNA agar. Targeted 16S rRNA gene
sequencing of bacterial DNA isolated from the CNA gavage
inocula identified Firmicutes species (Table S2). We concluded
that these species could colonize antibiotic-treated dnKO mice
without inducing disease. In contrast, antibiotic-pretreated
dnKO mice gavaged with the LKV culture developed robust392 Cell Host & Microbe 9, 390–403, May 19, 2011 ª2011 Elsevier Indisease similar to mice given the nonselective ANB culture
(Figures 3B–3E). These results suggested that abundant Gram-
negative obligate anaerobes were sufficient to induce disease
in dnKO mice.
CommensalBacteroides Isolates Induce Disease in IBD-
Susceptible, but Not IBD-Nonsusceptible, Mice
We therefore isolated and identified abundant Gram-negative,
obligate anaerobes from the stock of pooled intestinal contents
described above. We isolated and propagated 17 Gram-nega-
tive isolates on LKV agar. 16S rRNA gene sequence analysis
identified several redundant isolates that included six unique
species from the phylum Bacteroidetes (Table S3). Isolation ofc.
Figure 2. A Non-Germ-free System for Colitis Induction in Antibiotic-Pretreated dnKO Mice
(A) Experimental timeline. Antibiotic treatment began at weaning (age 3 weeks); mice were antibiotic treated forR3 weeks and gavaged 2 days after treatment
cessation (Abx = antibiotics).
(B) Representative images of H&E-stained rectal histology of antibiotic-pretreated dnKO mice orogastrically gavaged with sterile PBS or with a standardized
frozen stock of intestinal contents from untreated animals. Gavage dose = 2 3 107 total cfu/mouse on Anaerobic Reducible Blood (ANB) agar (nonselective
anaerobic culture media; cfu = colony-forming unit). Scale bar = 100 mm.
(C and D) Cecum and transverse colon pathology scores of antibiotic-pretreated dnKO mice gavaged with sterile PBS or intestinal contents from untreated
donors, as described in (B), displayed as individual (symbols) and median (bars) scores. Mann-Whitney U test.
(E–H) Transverse colon and rectum crypt heights and crypt widths of mice described in (C) and (D), displayed asmean ± SEM. Unpaired t test. See also Figure S2.
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Bacteroides Induce Disease in Mice with IBDunique-appearing colonies from intestinal contents grown in
parallel on Bacteroides bile esculin (BBE) agar produced nine
additional Bacteroidetes isolates, all of which were identical to
isolates obtained using LKV agar. Sequences from all isolates
were R99% identical to 16S rRNA sequences previously de-
tected in culture-independent studies of rodent commensal
intestinal microbiota, as determined using BLAST and theCellRibosomal Database Project (Cole et al., 2007, 2009). Collec-
tively, these results confirmed the isolates were common,
abundant members of the commensal microbiota.
To assesswhether any of the isolates could inducedisease,we
screened five of them in antibiotic-pretreated dnKO mice. We
found that pure cultures of each induced colitis to varying deg-
rees. Bacteroides vulgatus and Bacteroides thetaiotaomicronHost & Microbe 9, 390–403, May 19, 2011 ª2011 Elsevier Inc. 393
Figure 3. Mixed Cultures of Intestinal Contents Induce Disease in Antibiotic-Pretreated dnKO Mice
(A) Diagram of mixed culture preparation. Aliquots of intestinal contents (Figure 2B) were serially diluted and cultured on the indicated media types. Three day
mixed cultures were harvested from the indicated culture plates (in squares) and frozen in 20% glycerol. Aliquots of each culture were subsequently thawed and
adjusted to standardized doses for gavage.
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Cell Host & Microbe
Bacteroides Induce Disease in Mice with IBDinduced severe ulcerative disease, while theBacteroides sp. TP5
induced milder disease consisting of lymphocytic infiltrate in the
mucosa (Figures 4A and 4B).
Importantly, we confirmed that B. thetaiotaomicron, a well-
characterized symbiotic species (Goodman et al., 2009),
potently induced colitis in dnKO mice, but was innocuous in
Il10r2+/ controls (Figures 4C–4H and S3). The pathology in the
colonized dnKO mice included a significant colonic neutrophil
infiltration with transepithelial migration (Figure 4I) and a signifi-
cant increase in the percentage of interferon-producing CD4+
T cells isolated from the lamina propria (Figure 4J). These find-
ings were similar to those for untreated, spontaneously colitic
dnKO mice (Kang et al., 2008).
Serum antibody responses to commensal bacterial antigens
occur in IBD, but assessing cause and effect has been experi-
mentally challenging (Brandwein et al., 1997; Lodes et al.,
2004). We found that antibiotic-pretreated mice exhibited no
serum IgG response to lysates of cultured Bacteroidetes
species prior to gavage. In contrast, dnKO mice given either
B. thetaiotaomicron or B. vulgatus developed robust IgG
responses to multiple antigens of the respective isolate after
gavage, whereas Il10r2+/controls given the same bacteria did
not (Figures 4K and S3B). These results demonstrate that colitis
induced by commensal Bacteroides species involves activation
of both innate and adaptive immune responses in a host-geno-
type-specific fashion.
Antibiotic Treatment Eliminates Cultivable Intestinal
Bacteroides from the Fecal Microbiota
As diverse intestinal Bacteroidetes species induced colitis in
dnKO mice, we reasoned that antibiotic treatment should erad-
icate them from the microbiota. To test this hypothesis, we per-
formed quantitative fecal cultures on Bacteroides-selective
media. Fecal samples from antibiotic-treated dnKO mice ex-
hibited no bacterial growth on BBE agar at a detection limit of
17 colony-forming units (cfu) per sample (103 cfu/g of feces).
In contrast, samples from untreated dnKO mice resulted in
high bacterial titers (109 cfu/g of feces) on BBE agar (Figure 5A).
While antibiotic treatment decreased the total bacterial load as
assessed by qPCR for the bacterial rpob gene (Nava et al.,
2011), fecal titers on ANB media did not differ with antibiotic
treatment (Figures 5A and S4A). These data confirmed that anti-
biotics prevented disease by selectively altering microbiota
composition rather than by sterilizing the gut.
Commensal Bacteroides Species Fulfill Koch’s
Postulates in Host-Genotype-Specific Fashion
We could thus fulfill Koch’s postulates for commensal Bacter-
oides species by performing serial, quantitative fecal cultures
on BBE agar from single-isolate-gavaged mice. Antibiotic-pre-
treated mice gavaged with PBS remained free of cultivable
Bacteroides for up to 28 weeks, confirming absence of cage-to-(B and C) Cecum and transverse colon pathology scores of antibiotic-pretreated
cultures of intestinal contents mixed 1:1 with aerobic cultures grown on chocolate
displayed. Gavage doses: ANB = 6.43 107 total cfu/mouse; LKV = 7.33 107 total
PBS determined by Dunn’s multiple comparison test: not significant, p > 0.05; *p
(D and E) Transverse colon and rectum crypt heights of antibiotic-pretreated
significance relative to PBS determined by Dunnett’s multiple comparison test. T
Cellcagemicrobial contamination (Figures 5B and S4B). By contrast,
mice given pure cultures of B. thetaiotaomicron, B. vulgatus, or
Bacteroides species TP5 became stably colonized at 1010
cfu/g of feces (Figures 5B, 5C, and S4B) (data not shown). Bacte-
rial identity was determined by characteristic colony size,
morphology, and pigmentation pattern as well as 16S rRNA
gene sequence (Figures S4C and S4D). Colonization levels
were consistent from animal to animal and experiment to experi-
ment (Figure 5C). Antibiotic-pretreated Il10r2+/ and dnKO mice
became stably colonized with gavaged bacteria at equivalent
levels (Figures 5B and 5C) (data not shown). These results
demonstrated that disease inductionwas host genotype specific.
Commensal Enterobacteriaceae, but Not Bacteroides,
Are Strikingly Enriched in the Microbiota during
Spontaneous Disease
Despite our finding that commensalBacteroides induced colitis in
dnKO mice, studies of Bacteroides dynamics in the intestinal mi-
crobiota of both IBD patients and animal IBD models have
producedvariable results,withseveral studiesdetectingnosignif-
icant disease-associatedenrichment (Dicksvedet al., 2008; Frank
et al., 2007;Onderdonk et al., 1998;Ott et al., 2008; Takaishi et al.,
2008). We therefore examined fecal Bacteroides levels using
quantitative titers on BBE agar and qPCR species-specific
primers for the B. thetaiotaomicron 16S rRNA gene (Figures 6A,
6B, 6D, 6F, and S5). We found no significant difference between
untreated dnKO (spontaneously colitic) and Il10r2+/ (noncolitic)
mice by either of these methods. In contrast, previous studies
found an IBD-associated enrichment of Enterobacteriaceae
(Gram-negative, facultative anaerobes including Escherichia
coli from the phylum Proteobacteria that can be selectively
cultured on MacConkey agar) (Burke, 1997; Darfeuille-Michaud
et al., 1998; Frank et al., 2007; Onderdonk et al., 1998). In agree-
ment with these studies, we found commensal Enterobacteria-
ceaewere strikingly enriched in spontaneousdisease, accounting
for 50% of total cultivable fecal bacteria in dnKO mice, as
compared to <0.5% in cohoused Il10r2+/ controls (Figures 6A,
6C, 6E, and S5).
Commensal Enterobacteriaceae Are Not Sufficient
for Disease Induction
The elevation of Enterobacteriaceae in IBD led to the hypothesis
that these bacteria play a pathogenic role in disease (Burke,
1997; Frank et al., 2007; Onderdonk et al., 1998). However, it is
unclear whether Enterobacteriaceae enrichment is a cause or
effect of disease, because enrichment also occurs during non-
IBD intestinal inflammation experimentally induced by chemicals
ormicrobial pathogens (Heimesaat et al., 2006; Lupp et al., 2007;
Stecher et al., 2007). We found commensal Enterobacteriaceae
were eliminated from antibiotic-treated mice (Figure 6C), allow-
ing us to directly test their colitogenic activity. We isolated an
Enterobacteriaceae species that was highly enriched in the fecesdnKO mice gavaged with sterile PBS or with the indicated anaerobic mixed
agar at 0 dilution. Individual (symbols) and median (bars) pathology scores are
cfu/mouse; CNA = 5.43 107 total cfu/mouse. Statistical significance relative to
< 0.05; **p < 0.01.
dnKO mice described in (B) and (C), displayed as mean ± SEM. Statistical
he screen was unrepeated. See also Tables S1A and S1B.
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Figure 4. Commensal Bacteroides Induce Disease in Antibiotic-Pretreated dnKO, but Not Il10r2+/–, Mice
(A) Screen for colitis induction by Bacteroidetes isolates. Cecum gross pathology scores of antibiotic-pretreated dnKOmice gavaged with 13 108 cfu/mouse of
pure cultures of the indicated primary bacterial isolates (see Table S3). Not repeated for B. uniformis and P. goldsteinii.
(B) Representative H&E-stained cecal histology ofmice gavagedwith pure cultures of the indicated bacterial isolate as described in (A). Scale bar = 200 mm.Cecal
histology of a noncolitic Il10r2+/ mouse gavaged with B. thetaiotaomicron is shown for comparison.
(C and D) Cecum and transverse colon pathology scores of antibiotic-pretreated mice of the indicated genotypes gavaged with PBS or a pure culture of the
Bacteroides thetaiotaomicron isolate (73 107 cfu/mouse). Kruskal-Wallis test with post hoc Dunn’s test. H2 = 12.26, p = 0.0022 (C); H2 = 11.36, p = 0.0034 (D). All
significant pairwise comparisons are displayed: *p < 0.05.
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Figure 5. Intestinal Bacteroides Are Eliminated by Antibiotics and Stably Recolonize Gavaged, Antibiotic-Pretreated Mice Independently
of Host Genotype
(A) Plot of fecal titers from untreated and antibiotic-treated dnKO mice grown in parallel anaerobically on nonselective (ANB) agar and Bacteroides bile esculin
(BBE) agar. Titers from individual mice (symbols) and means of log10-transformed titers (bars) are displayed. Unpaired t test (log10-transformed titers).
(B) Plot of serial fecal titers on BBE agar from antibiotic-pretreated mice gavaged on Day 0 with sterile PBS or B. thetaiotaomicron (73 107 cfu/mouse). Individual
titers (symbols) and means of log10-transformed titers (lines) are displayed. Unpaired t tests compare log10-transformed titers from B. thetaiotaomicron-gavaged
dnKO and Il10r2+/ mice.
(C) Frequency histogram of all 92 B. thetaiotaomicron fecal titer measurements (log10-transformed) we performed on individual, single-isolate-gavaged, anti-
biotic-pretreated mice regardless of mouse genotype. Fecal titers were performed between 6 and 20 days postgavage; data are compiled from multiple
independent experiments with 4–9 mice per experiment. Gavage doses ranged from 6.63 107 to 8.6 3 108 cfu/mouse. Excluding the single outlier value (8.78),
the titers are normally distributed as assessed by the D’Agostino Pearson K2 omnibus normality test: p = 0.5894, K2 = 1.057, skewness = 0.153, kurtosis =
0.3345. See also Figure S4.
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Bacteroides Induce Disease in Mice with IBDof an untreated, colitic dnKO mouse (33% of total cultivable
bacteria) and identified it as E. coli by 16S rRNA sequence anal-
ysis and phenotypic characterization (Figure S6). To test the
isolate’s disease-inducing potential, we gavaged it into antibi-
otic-pretreated dnKO mice. Other groups of dnKO mice were
gavaged with B. thetaiotaomicron or sterile PBS, as positive
and negative controls. We quantified bacterial colonization by
performing serial fecal titers on BBE and MacConkey agar
(Figures 7A and 7B). E. coli stably colonized antibiotic-pretreated
animals at higher levels than those observed in untreated dnKO(E–H) Transverse colon and rectum crypt heights and crypt widths of mice descr
Tukey’s test: F2,10 = 8.596, p = 0.0067 (E); F2,10 = 12.55, p = 0.0019 (F); F2,10 =
comparisons are displayed if the omnibus p value by ANOVA was significant: *p
(I) Graph of the number of neutrophils per 50well-oriented crypts locatedwithin the
Kruskal-Wallis test: H2 = 6.529, p = 0.0382.
(J)PercentofCD4+Tcells expressing Ifng, determinedusingvalidatedprocedures
2) and dnKO (n = 4) mice or antibiotic-pretreated Il10r2+/ (n = 3) and dnKO (n = 3) m
postgavage. One-way ANOVA with post hoc Tukey’s test: F3,8 = 27.93, p = 0.000
(K) Immunoblots of B. thetaiotaomicron lysate probed with a 1:200 dilution of p
collected immediately prior to gavage with 108 cfu/mouse of B. thetaiotaomicron
a-mouse IgG. Equal amounts of bacterial lysate were separated by SDS-PAGE, t
groups. See also Table S3 and Figure S3.
Cellmice (compare Figures 6C and 7B). However, E. coli did
not induce significant disease relative to PBS, whereas
B. thetaiotaomicron induced significant disease relative to both
E. coli and PBS (Figures 7C–7H).
DISCUSSION
The commensal microbiota influences pathogenesis of many
diseases, including IBD, but the role of specific microbes is
incompletely understood. Two central, related questions areibed in (C) and (D), displayed as mean ± SEM, one-way ANOVA with post hoc
2.057, p = 0.1786 (G); F2,10 = 12.05, p = 0.0022 (H). All significant pairwise
< 0.05; **p < 0.01.
intestinal epithelium/crypt lumen in colons of themice described in (C) and (D).
(Kanget al., 2008), in thecolonic laminapropriaof antibiotic-treated Il10r2+/ (n=
ice gavagedwith 108 cfu/mouse ofB. thetaiotaomicron and sacrificed 3weeks
1. All significant pairwise comparisons are displayed: **p < 0.01; ***p < 0.005.
ooled serum from antibiotic-pretreated Il10r2+/ (n = 3) or dnKO (n = 8) mice
(pregavage) or at sacrifice 3 weeks later (postgavage). Secondary antibody is
ransferred to nitrocellulose membranes, blotted, and exposed in parallel for all
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Figure 6. Commensal Enterobacteriaceae Are Enriched in Spontaneous Colitis
(A–C) Plot of fecal titers from untreated or antibiotic-treatedmice of the indicated genotypes grown in parallel anaerobically on ANB and BBE agar and aerobically
on MacConkey agar (selective for Enterobacteriaceae). Il10r2+/ and dnKO mice were cohoused; data compiled from R2 cages/group. One-way ANOVA
(ANB titers: F3,13 = 1.344, p = 0.3031) or unpaired t test (log10-transformed titers).
(D and E) Proportions of total cultivable bacteria in Figures (A)–(C) that grew on BBE agar andMacConkey agar, calculated by dividing BBE andMacConkey titers
by ANB titers. Displayed as individual (symbols) and means of log10-transformed proportions (bars). Unpaired t test (log10-transformed proportions).
(F) Plots of fecal samples from untreated and antibiotic-treated dnKO and Il10r2+/ mice (n = 6 per group) analyzed by qPCR using primers specific for the
B. thetaiotaomicron 16S rRNA gene. Il10r2+/ and dnKO mice within each treatment group were cohoused; data compiled from R3 cages/group. Results of
qPCR assays were normalized to sample weight. Mann-Whitney U test (log10-transformed values). See also Figure S5.
Cell Host & Microbe
Bacteroides Induce Disease in Mice with IBDwhether specific commensal bacterial subsets induce IBD and, if
so, whether their proportions in the microbiota are altered during
disease (Strober, 2010; Takaishi et al., 2008; Tannock, 2008). To
address these questions, we utilized an antibiotic-responsive
genetic mouse model with defects in IL-10 and TGF-b signaling,
both of which are associated with human IBD (Franke et al.,
2010; Glocker et al., 2009; McGovern et al., 2010). Using these
mice, we developed a non-germ-free approach to screen for
specific disease-inducing commensal bacteria. Based on the
results of this screen, we fulfilled host-genotype-specific Koch’s
postulates for commensal Bacteroides species. We isolated
Bacteroides species that were common to susceptible and non-
susceptible hosts and were eliminated by disease-blocking
antibiotics. We administered pure cultures of the isolates to anti-
biotic-pretreated mice and found that they induced colitis with
features of adaptive and innate immunopathology in susceptible
hosts but not in nonsusceptible hosts. Importantly, Bacteroides
species could be quantitatively reisolated from experimentally
colonized animals at equivalent levels regardless of host geno-398 Cell Host & Microbe 9, 390–403, May 19, 2011 ª2011 Elsevier Intype and disease status. These results suggest the genotype-
dependent disparity in disease induction was due to differences
in host response rather than altered colonization susceptibility.
Conversely, commensal Enterobacteriaceae were strikingly en-
riched in the microbiota during spontaneous disease, but
a colitis-enriched Enterobacteriaceae isolate was not sufficient
to induce disease, despite robust colonization. We further found
that antibiotic-treated, noncolitic dnKO mice were colonized at
high levels with bacteria belonging to several families of Firmi-
cutes. We thus identified distinct subsets of commensal bacteria
with and without disease-inducing potential and demonstrated
that the colitogenicity of these subsets would not have been pre-
dicted based on disease-associated shifts in colonization.
Identification of specific IBD-inducing commensal microbes
has been a longstanding goal (Burke, 1997; Sartor, 2008).
Germ-free animals are frequently used as they provide a source
of healthy yet susceptible hosts for experimental colonization
with defined microbial populations. Determining colonization
levels of introduced isolates in ex-germ-free animals isc.
Figure 7. A Colitis-Enriched Commensal Enterobacteriaceae Isolate Robustly Colonizes Antibiotic-Pretreated dnKO Mice without Disease
Induction
(A and B) Plot of serial fecal titers grown on BBE and MacConkey agar from antibiotic-pretreated dnKO mice (5–6 per group) gavaged with PBS,
B. thetaiotaomicron (1 3 108 cfu/mouse), or Escherichia coli (2 3 108 cfu/mouse). Bacterial identity was determined by colony characteristics, confirmed by
sequencing the 16S rRNA gene of representative colonies.
(C and D) Cecum and transverse colon pathology scores of mice described in (A) and (B) displayed as individual (symbols) and median (bars) scores. Kruskal-
Wallis test with post hoc Dunn’s tests: H2 = 11.49, p = 0.0032 (C); H2 = 12.02, p = 0.0025 (D). All significant pairwise comparisons are displayed: *p < 0.05;
**p < 0.01.
(E–H) Transverse colon and rectum crypt heights and crypt widths frommice described in (A) and (B), displayed as mean ± SEM, one-way ANOVA with post hoc
Tukey’s test: F2,14 = 2.580, p = 0.1112 (E); F2,14 = 5.434 (F); p = 0.0179; F2,14 = 6.438, p = 0.0104 (G); F2,14 = 7.268, p = 0.0068 (H). All significant pairwise
comparisons are displayed if omnibus p value by ANOVA was significant: *p < 0.05. See also Figure S6.
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Bacteroides Induce Disease in Mice with IBDuncomplicated, and host effects can be directly attributed to the
introduced bacteria (Hapfelmeier et al., 2010).While such studies
show the microbiota play a role in disease induction, there are
important caveats for using them to identify specific disease-
inducing bacteria. Importantly, the innate and adaptive immune
system of germ-free animals is immature (Ivanov et al., 2009;
Lee and Mazmanian, 2010), and bacteria that induce chronic
inflammation or cancer in conventionally raised animals can
produce dramatically different outcomes in germ-free hosts,
ranging from no disease induction to rapid death (Garrett et al.,
2010; Lofgren et al., 2011; Rhee et al., 2009). These results high-Celllight the need for new strategies to identify and characterize
disease-inducing bacteria. The non-germ-free approach we
developed here generates healthy, IBD-susceptible mice by pre-
treating conventionally raised animals with antibiotics that have
been widely studied in human IBD (Elahi et al., 2009; Ohkusa
et al., 2010; Rahimi et al., 2006). Antibiotic treatment eradicated
certain bacterial subsets from the microbiota, enabling us to
experimentally colonize antibiotic-pretreated animals with
primary isolates of commensal bacteria indigenous to our mouse
colony and specifically quantify colonization. Interestingly, the
isolates colonized antibiotic-pretreated mice at levels higherHost & Microbe 9, 390–403, May 19, 2011 ª2011 Elsevier Inc. 399
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Bacteroides Induce Disease in Mice with IBDthan those observed in untreated animals, suggesting antibiotics
produce an alteredmicrobial ecosystempermissive to expansion
of individually reintroduced commensal species. This approach
should be broadly applicable to a wide range of animal models
and disease processes.
Multiple commensal Bacteroides species including B. thetaio-
taomicron and B. vulgatus induced disease in antibiotic-pre-
treated dnKO mice. Intestinal Bacteroides are among the most
abundant and well studied members of the commensal micro-
biota. They benefit the host through breakdown of complex die-
tary carbohydrates and modulation of mucosal glycosylation,
gene expression, angiogenesis, and immune maturation (Com-
stock, 2009; Hooper et al., 2001; Round and Mazmanian,
2010; Stappenbeck et al., 2002; Xu et al., 2007). To our knowl-
edge, B. thetaiotaomicron has not previously been implicated
in IBD pathogenesis. Conflicting data exist on the role of
B. vulgatus in IBD. Germ-free rats transgenically expressing
HLA-B27, a human MHC class I allele linked to spondyloarthri-
tis-associated IBD (Brakenhoff et al., 2010), developed T cell-
dependent colitis when colonized with B. vulgatus but not with
other bacteria, including E. coli (Hoentjen et al., 2007; Rath
et al., 1999). Interestingly, E. coli, but not Bacteroides, species
were enriched in conventionally raised, spontaneously colitic
transgenic rats (Onderdonk et al., 1998).B. vulgatus colonization
also induced disease in germ-free guinea pigs treatedwith carra-
geenan (Onderdonk et al., 1983). However, B. vulgatus did not
induce disease in germ-free Il10/mice and appeared to be
protective in germ-free Il2/ mice, whereas some strains of
E. coli were colitogenic (Kim et al., 2007; Sellon et al., 1998;
Waidmann et al., 2003). The Il10/ and Il2/mice used in those
studies were on different genetic backgrounds than the dnKO
mice we used here, making it unclear whether results differed
due to host genetic differences or because our studies were per-
formed in conventionally raised rather than germ-free animals.
Given the human-relevant genetic features of dnKO mice and
the use of a non-germ-free approach, our findings suggest
commensal Bacteroides species may have specific colitogenic
effects in at least a subset of human IBD. Mazmanian and
colleagues recently coined the term ‘‘pathobiont’’ to describe
commensal or symbiotic microbes that induce disease only in
certain genetic or environmental contexts (Chow and Mazma-
nian, 2010; Mazmanian et al., 2008). We propose that fulfillment
of host-genotype-specific Koch’s postulates in dnKO mice
demonstrates that commensal Bacteroides species act as path-
obionts in this genetic context.
Shifts in specific commensal intestinal bacterial subsets occur
in IBD and notably include enrichment of Enterobacteriaceae
and other Proteobacteria (Burke, 1997; Darfeuille-Michaud
et al., 1998; Frank et al., 2007; Takaishi et al., 2008). Our finding
that a colitis-enriched E. coli isolate did not induce disease in
antibiotic-pretreated dnKO mice adds to a growing body of
evidence that intestinal inflammation provides both commensal
and pathogenic Enterobacteriaceae with a selective colonization
advantage regardless of inflammation etiology (Heimesaat et al.,
2006; Lupp et al., 2007; Stecher et al., 2007; Winter et al., 2010).
Interestingly, Proteobacteria enrichment also occurs in the lung
microbiota of asthma patients (Hilty et al., 2010) and the gastric
microbiota of patients with Helicobacter pylori-induced chronic
atrophic gastritis (Maldonado-Contreras et al., 2011). The path-400 Cell Host & Microbe 9, 390–403, May 19, 2011 ª2011 Elsevier Inogenic Enterobacteriaceae species Salmonella typhimurium
directly exploits intestinal inflammation by using tetrathio-
nate—a compound generated in the presence of host-derived
reactive oxygen species—as a respiratory electron acceptor to
outcompete the commensal bacteria (Winter et al., 2010). We
speculate that analogous mechanisms for exploiting mucosal
inflammation may account for Enterobacteriaceae enrichment
in IBD and might also be related to the frequency with which
nonpathogenic Enterobacteriaceae strains have independently
and convergently evolved pathogenic phenotypes (Pupo et al.,
1997; Wirth et al., 2006). Thus, although colitis-enriched
bacteria, including some Enterobacteriaceae, may play proco-
litic roles in certain circumstances (Darfeuille-Michaud et al.,
1998; Garrett et al., 2010), our findings underscore the impor-
tance of functionally assessing a microbe’s disease-inducing
potential rather than simply extrapolating from disease-associ-
ated shifts in microbiota composition.
In summary, our results provide important insights into the
intestinal microbiota’s role in IBD induction. This work does not
support models in which a single microbial species is both
necessary and sufficient for disease to occur, nor canwe exclude
the possibility that additional commensal species unexamined in
our study may also be capable of disease induction. Nonethe-
less, we provide evidence that specific bacterial subsets can
induce IBD, whereas other subsets cannot. We demonstrate
that the identification and validation of these subsets is experi-
mentally feasible. As additional spontaneous animal models of
IBD based on other human susceptibility mutations become
available, the experimental criteria and conceptual framework
developed here will allow the contributions of commensal
bacteria to be assessed in additional genetic contexts.
EXPERIMENTAL PROCEDURES
Mouse Care
Animal protocols were approved by Washington University’s Animal Studies
Committee. Breedingand antibiotic treatment (ciprofloxacin andmetronidazole)
of dnKO mice (CD4-dnTgfbr2; Il10r2/) was previously described (Kang et al.,
2008) (Supplemental Experimental Procedures). Il10r2+/ littermates served as
controls. For colonization experiments, antibiotic-pretreated mice (R3 weeks)
were gavaged 2 days after treatment cessation and euthanized 3 weeks post-
gavageorupon lossofR30%ofmaximumbodyweight.Dataare representative
of at least two independent experiments per group unless otherwise indicated.
Gross Pathology Scores and Histologic Quantification of Mucosal
Inflammation
Tissues were fixed and prepared for gross pathology scoring and histologic
analysis as previously described (Figure S1 and Supplemental Experimental
Procedures) (Kang et al., 2008).
Fecal Bacterial DNA Extraction and qPCR
Fecal pellets were collected, and bacterial DNA was extracted for quantifica-
tion by qPCR assays using rpob or group-specific 16S rRNA primers (Nava
et al., 2010) (Supplemental Experimental Procedures).
Intestinal Content and Mixed Culture Preparation
All anaerobic bacteriology and manipulation of uncultured intestinal contents
was performed in an anaerobic glove box. Cecal contents were harvested
from untreated littermates of dnKO mice, suspended in PBS/glycerol, and
stored at80C in single-use aliquots. Mixed bacterial cultures were prepared
from aliquots of intestinal contents and cultured in parallel on various media
types (Supplemental Experimental Procedures).c.
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Fecal bacteria were cultured on nonselective ANB agar. Pure cultures were
identifiedby16S rRNAgeneanalysis (Supplemental Experimental Procedures).
Gram-negative anaerobes were isolated on LKV or BBE agar from stocks
of intestinal contents (Table S1). E. coli for gavage experiments (Figure S5)
was isolated on ANB agar from feces of an untreated dnKO mouse and
identified by 16S rRNA gene analysis (Supplemental Experimental
Procedures).
Gavage Experiments
Titers of frozen stock inocula were determined prior to use in colonization
experiments. Aliquots of gavage inocula were volume-adjusted in sterile
PBS in the anaerobic chamber and immediately transported to the mouse
facility for orogastric gavage (Goodman et al., 2009). Gavage doses were
confirmed by back-titering the inocula.
Titration of Fecal Bacteria
Fecal samples were titered on ANB, BBE, or MacConkey agar (Supplemental
Experimental Procedures). Identity of bacteria on BBE and MacConkey titer
plates from single-isolate-gavaged mice was confirmed by 16S rRNA gene
sequence analysis.
Serum Immunoblots
Lysates of B. thetaiotoaomicron or B. vulgatuswere separated by SDS-PAGE,
transferred to nitrocellulose membranes, and probed with pre- or postgavage
serum collected from antibiotic-pretreated mice gavaged with pure cultures of
the respective isolate (Supplemental Experimental Procedures). Goat anti-
mouse IgG was used as a secondary probe.
Statistical Analysis
Statistical analysis was performed using Prism (GraphPad Software) and
SPSS (SPSS Inc.) (Supplemental Experimental Procedures). Statistical signif-
icance was defined as p < 0.05; p values are two tailed.
ACCESSION NUMBERS
All bacterial sequences were deposited in GenBank (JF813174–JF813185).
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, three tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at doi:10.1016/j.chom.2011.04.009.
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